查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015175

非手術皮膚緊緻市場：依技術、應用、終端用戶和通路分類－2026-2032年全球市場預測

Non-surgical Skin Tightening Market by Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，非手術皮膚緊緻市場價值將達到 15.6 億美元，到 2026 年將成長至 16.5 億美元，到 2032 年將達到 24.5 億美元，年複合成長率為 6.63%。

主要市場統計數據
基準年 2025 15.6億美元
預計年份：2026年 16.5億美元
預測年份 2032 24.5億美元
複合年成長率 (%) 6.63%

權威地介紹了非手術皮膚緊緻的現狀，其中設備創新、臨床接受度和患者偏好正在融合。

非手術緊膚市場正處於轉折點，其驅動力包括技術的進步、臨床認可的提高以及患者偏好的轉變。新型設備技術和現有平台的改進正在拓展臨床醫生和美容醫學專業人士可選擇的治療方案範圍，同時消費者對微創治療的需求也持續成長。臨床醫生擴大將先進治療方法納入治療方案，力求在療效、安全性和患者恢復時間之間取得平衡，這種務實的採納正在重塑採購和臨床培訓的優先事項。

技術融合、數位化病人參與和實證臨床實踐如何重新定義產業的治療路徑。

近年來，技術進步、臨床工作流程的轉變以及消費行為的改變，推動了非手術皮膚緊緻領域的變革。能量型治療平台已從單一模式發展到更一體化的解決方案，使臨床醫生能夠根據組織深度和解剖位置量身定做治療方案。因此，患者的治療路徑更加個人化，更注重療效，醫生也開始結合多種治療模式來應對不同的組織特徵。

本研究評估了 2025 年關稅措施對臨床和商業生態系統中的採購、定價和籌資策略的實際影響。

美國將於2025年開始實施累積關稅，這為非手術皮膚緊緻設備及耗材的採購、供應鏈規劃和定價策略帶來了複雜性。關稅的累積增加了許多進口零件和成品的接收成本，迫使製造商和經銷商重新評估籌資策略、庫存政策以及與臨床客戶的合約條款。為此，眾多相關人員正在加快近岸外包和供應商多元化的步伐，以降低貿易波動帶來的風險。

透過對技術、解剖結構、最終用戶和銷售管道進行詳細的細分洞察，從而形成可操作的產品和商業化策略。

細分市場層面的理解能夠提供跨技術領域、臨床適應症、使用者類型和銷售管道的清晰訊息，從而實現有針對性的產品開發和個人化最佳化的商業性策略。從技術角度來看，紅外線設備涵蓋遠紅外線和近紅外線兩種類型，每種類型都適用於特定的組織相互作用特性。雷射平台包括二極體雷射、鉺雷射和Nd:YAG雷射，它們具有不同的穿透深度和髮色團相互作用。射頻系統提供雙極、單極和三極結構，可提供不同的深度和聚焦方式。超音波產品包括高強度聚焦超音波（HIFU）和微聚焦超音波設備，分別針對特定深度區域和膠原蛋白重塑動態。

區域監管差異、基礎設施成熟度和消費者行為如何塑造全球不同的商業和臨床策略。

區域趨勢對監管路徑、報銷考量、臨床應用和競爭格局產生顯著影響，從而在美洲、歐洲、中東和非洲以及亞太地區造成了不同的戰略挑戰。在美洲，高效醫療器材的發展環境較為有利，這得益於先進的臨床應用和蓬勃發展的美容服務產業；然而，相關人員必須應對不斷變化的支付方對話和醫療採購標準。同時，特定地區的監管政策清晰明確，消費者認知度高，這有利於高階產品定位和以臨床醫生主導的實證醫學發展。

創新者和成熟企業透過臨床證據、服務模式和多重模式平台實現差異化，從而採取競爭性和策略性行動。

非手術緊膚領域的競爭格局呈現出兩極化的態勢：一方面，創新者優先考慮差異化的能量輸送、服務生態系統和培訓；另一方面，成熟企業則強調廣泛的分銷網路和全面的臨床支持。市場領導正增加對臨床研究、平台多功能性和全生命週期服務的投入，以維護醫療專業人員的信任並降低其感知風險。同時，新興企業則瞄準細分市場，提案特定的設備、簡化的使用者介面和具有競爭力的定價策略，以吸引高績效醫療機構和價格敏感型客戶群。

實際的措施，幫助製造商和供應商提高臨床信譽度，簡化商業化流程，並降低供應鏈和政策風險。

產業領導者必須採取多管齊下的策略，結合產品創新、臨床夥伴關係和高度靈活的商業模式，才能應對這一領域的複雜性。優先投資於深化特定適應症和解剖區域的臨床證據，將提升臨床可信度，並與競爭治療方法形成更清晰的差異化。同時，最佳化設備設計，兼顧模組化和可製造性，可以在保持臨床功能的同時，降低關稅和供應鏈中斷帶來的風險。

我們採用高度透明的調查方法，反映臨床醫師的見解，將對臨床醫師的初步訪談與嚴格的二手證據結合，以得出切實可行的結論。

本分析所依據的研究整合了初步的質性研究結果和二手證據，從而對臨床應用、技術性能和商業性趨勢提供了嚴謹的觀點。初步資訊來自對臨床醫生、設備工程師、經銷商高管和臨床教育工作者的結構化訪談，這些訪談提供了關於治療流程、設備偏好和購買考慮的第一手觀點。研究人員將這些從業人員的意見與技術文獻、監管文件和公司資訊披露進行交叉比對，以檢驗有關設備功能和安全性的聲明。

簡潔的結論強調，臨床檢驗、強大的商業化和適應性強的產品策略之間的相互作用是未來成功的關鍵。

總而言之，隨著設備創新、臨床證據和消費者偏好的融合，非手術皮膚緊緻療法正步入一個穩定發展的成熟期，重塑治療路徑。能量模式在技術設計和臨床應用方面日益多樣化，需要精準定位，使設備功能與解剖結構和手術要求相匹配。區域法規結構、不斷變化的貿易政策和分銷管道影響著產品的推廣模式，這些因素共同為製造商、臨床醫生和經銷商創造了一個充滿活力的商業環境。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 非手術皮膚緊緻市場：依技術分類

  • 紅外線的
    • 遠紅外線
    • 近紅外線
  • 雷射
    • 二極體
    • 鉺
    • Nd：YAG
  • 高頻
    • 雙極
    • 單極
    • 三極體型
  • 超音波
    • 高強度聚焦超音波
    • 微聚焦超音波

第9章 非手術皮膚緊緻市場：依應用領域分類

  • 身體
    • 腹部
    • 手臂
    • 臀部
    • 大腿
  • 臉
    • 臉頰
    • 顎
    • 數量
    • 脖子

第10章 非手術皮膚緊緻市場：依最終使用者分類

  • 美容診所
  • 皮膚科診所
  • 家用
  • 醫院
  • 醫療水療中心

第11章 非手術皮膚緊緻市場：依通路分類

  • 離線
  • 線上

第12章 非手術皮膚緊緻市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 非手術皮膚緊緻市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 非手術皮膚緊緻市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國非手術皮膚緊緻市場

第16章：中國非手術緊膚市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BTL Industries, Inc.
  • Candela Corporation
  • Cutera, Inc.
  • Cynosure, LLC
  • El.En. SpA
  • InMode Ltd.
  • Lumenis Ltd.
  • Lutronic Corporation
  • Merz Pharma GmbH & Co. KGaA
  • Sisram Medical Ltd.
  • Venus Concept Ltd.
Product Code: MRR-036C5CF3B527

The Non-surgical Skin Tightening Market was valued at USD 1.56 billion in 2025 and is projected to grow to USD 1.65 billion in 2026, with a CAGR of 6.63%, reaching USD 2.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.56 billion
Estimated Year [2026] USD 1.65 billion
Forecast Year [2032] USD 2.45 billion
CAGR (%) 6.63%

An authoritative introduction to the evolving convergence of device innovation, clinical acceptance, and patient preferences in non-surgical skin tightening

The non-surgical skin tightening landscape is at an inflection point driven by technological refinement, expanding clinical acceptance, and evolving patient preferences. New device modalities and refinements of existing platforms are broadening the therapeutic envelope for clinicians and aesthetic practitioners, while consumer demand for minimally invasive options continues to grow. Clinicians are increasingly integrating advanced modalities into treatment protocols, balancing efficacy, safety, and patient downtime, and this pragmatic adoption is reshaping purchasing and clinical training priorities.

Technological convergence is notable, as devices leverage improved energy delivery, real-time feedback, and ergonomic designs to enhance outcomes. Concurrently, regulatory authorities are emphasizing evidence of clinical effectiveness and device safety, prompting manufacturers to invest in robust clinical programs and quality systems. These developments are occurring alongside shifting payer attitudes and increased interest in home-use devices, creating a multi-channel environment for product deployment.

Taken together, this dynamic environment calls for stakeholders to reassess product positioning, clinical education efforts, and distribution strategies. As innovation advances, the ability to articulate differentiated clinical benefits and to demonstrate reliable safety profiles will determine adoption curves. Therefore, strategic clarity and operational agility are required from manufacturers, clinicians, and channel partners to translate technological progress into sustainable clinical and commercial outcomes.

How technological convergence, digital patient engagement, and evidence-driven clinical practice are redefining treatment pathways in the industry

The last several years have produced transformative shifts across the non-surgical skin tightening spectrum, spurred by technological advances, changing clinical workflows, and novel consumer behaviors. Energy-based platforms have migrated from single-modality offerings to more integrated solutions that allow clinicians to customize treatments according to tissue depth and anatomic region. As a result, patient pathways are becoming more personalized and outcome-driven, with practitioners combining modalities to address heterogeneous tissue characteristics.

Simultaneously, digital health and teleconsultation capabilities are influencing pre-procedure assessment and follow-up care, enabling more consistent treatment planning and monitoring. This digital integration reduces friction in patient engagement, streamlines consent and education, and supports remote outcomes tracking. In parallel, the rise of credible at-home devices has broadened the continuum of care, prompting professionals to delineate clinic-administered and home-supported treatment regimens more clearly.

Clinical evidence generation has also shifted, with increasing emphasis on longitudinal outcomes and real-world data collection that better reflect routine practice. This emphasis enhances clinician confidence and supports reimbursement conversations in certain geographies. Together, these shifts are creating a landscape in which cross-disciplinary alliances, digital augmentation, and evidence-driven marketing become essential for organizations that aspire to lead the category.

Assessing the practical consequences of 2025 tariff measures on sourcing, pricing, and procurement strategies across the clinical and commercial ecosystem

The introduction of cumulative tariffs enacted by the United States in 2025 has introduced complexity across procurement, supply-chain planning, and pricing strategies for non-surgical skin tightening devices and consumables. Tariff layering has raised the landed cost for many imported components and finished devices, prompting manufacturers and distributors to reassess sourcing strategies, inventory policies, and contractual terms with clinical customers. In response, several stakeholders have accelerated nearshoring initiatives and supplier diversification to mitigate exposure to volatile trade measures.

Clinics and aesthetic centers have confronted tighter purchasing windows and the need to renegotiate capital acquisition plans, while some manufacturers have absorbed tariff-related cost increases temporarily to preserve competitive pricing and market momentum. At the same time, the tariff environment has incentivized innovation in component selection and design for manufacturability, with producers seeking alternate materials and simplified assemblies that reduce cross-border value addition and tariff liabilities.

Furthermore, tariff-induced price pressures have underscored the importance of comprehensive total-cost-of-ownership (TCO) analyses for buyers. Practitioners and institutional purchasers are placing greater emphasis on service agreements, consumable economics, and device longevity when evaluating investments. Consequently, business models that incorporate flexible financing, extended warranty options, and bundled service plans are gaining traction as pragmatic responses to trade-driven cost fluctuations.

Deep segmentation insights linking technologies, anatomies, end-users, and channels to actionable product and commercialization strategies

Segment-level understanding provides actionable clarity across technology corridors, clinical indications, user types, and channels, enabling targeted product development and tailored commercial approaches. In technology terms, infrared devices span far infrared and near infrared variants, each suited to specific tissue interaction profiles; laser platforms include diode, erbium, and Nd:YAG configurations with differentiated penetration and chromophore interactions; radio frequency systems present bipolar, monopolar, and tripolar architectures delivering varied depth and focality; and ultrasound offerings comprise high intensity focused ultrasound and microfocused ultrasound devices that address discrete depth zones and collagen remodeling dynamics.

Application segmentation differentiates body and face needs. Body treatments concentrate on regions such as the abdomen, arms, buttocks, and thighs where larger treatment fields and adipose considerations inform device selection and treatment protocols, whereas facial applications emphasize cheeks, chin, forehead, and neck areas that require precision energy delivery and minimal downtime. End-user segmentation further refines go-to-market priorities: aesthetic centers and dermatology clinics typically prioritize performance, serviceability, and training support; hospitals may emphasize regulatory compliance and multi-specialty utility; medical spas balance cost and patient throughput; and the emergence of home-use solutions has introduced consumer-driven product design and simplified user interfaces.

Distribution channels also shape adoption dynamics, with offline pathways enabling hands-on demonstrations and clinical partnerships, while online channels offer scalability, direct-to-consumer engagement, and digital marketing efficiencies. Insights at the segment level guide messaging, clinical evidence generation, and channel incentives to align with the operational realities and purchasing behaviors of each cohort.

How regional regulatory variance, infrastructure maturity, and consumer behavior shape differentiated commercial and clinical strategies across global regions

Regional dynamics exert profound influence over regulatory pathways, reimbursement considerations, clinical adoption, and competitive intensity, creating distinct strategic imperatives within the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, advanced clinical adoption and a robust aesthetic services sector create a receptive environment for high-efficacy devices, yet stakeholders must navigate evolving payer conversations and institutional procurement norms. Meanwhile, regulatory clarity and high consumer awareness in certain jurisdictions support premium positioning and clinician-led evidence development.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable clinical infrastructures demand localized approaches that balance centralized clinical studies with region-specific training and service support. Strategic partnerships and distributor models that deliver regulatory expertise and localized clinical education are frequently necessary to accelerate adoption. In the Asia-Pacific, rapid clinical uptake in urban centers, strong manufacturing ecosystems, and price-sensitive segments coexist; this duality rewards product modularity and manufacturing cost efficiencies while offering scale for firms able to tailor offerings across emerging and mature markets.

Understanding these regional contours enables companies to prioritize regulatory investments, calibrate clinical evidence strategies, and tailor commercial models. Moreover, regional considerations inform supply-chain decisions, channel mix, and collaboration approaches with local clinical opinion leaders to maximize clinical credibility and operational viability.

Competitive dynamics and strategic behaviors of innovators and incumbents driving differentiation through clinical evidence, service models, and multi-modality platforms

The competitive constellation in non-surgical skin tightening includes innovators that prioritize differentiated energy delivery, service ecosystems, and training, alongside established firms that emphasize distribution reach and comprehensive clinical support. Market leaders are investing in clinical research, platform versatility, and lifecycle services to sustain practitioner confidence and to reduce perceived risk. At the same time, challenger firms target niche opportunities with focused device propositions, streamlined user interfaces, and competitive pricing strategies that resonate with high-volume practices and price-sensitive segments.

Commercial emphasis increasingly favors integrated solutions that combine multi-modality capability with enhanced ergonomics and data capture for outcomes tracking. Strategic collaborations between device makers and clinical research institutions are becoming more common, providing the clinical validation necessary for broader professional acceptance. In parallel, after-sales services, including responsive technical support, consumable supply assurance, and scalable training programs, are key differentiators influencing purchasing decisions and long-term loyalty.

Furthermore, new entrants are leveraging digital marketing and direct-to-provider engagement to shorten sales cycles, while incumbents are reinforcing distributor relationships and expanding service footprints. The competitive imperative is to balance innovation velocity with durable operational excellence, thereby ensuring that clinical performance, safety, and commercial serviceability align with practitioner and patient expectations.

Practical, high-impact actions for manufacturers and providers to strengthen clinical credibility, streamline commercialization, and mitigate supply-chain and policy risks

Industry leaders must adopt a multi-dimensional strategy that combines product innovation, clinical partnerships, and adaptive commercial models to navigate the complexities of the category. Prioritizing investments that deepen clinical evidence for specific indications and anatomical zones will strengthen clinical credibility and enable clearer differentiation from competing modalities. Simultaneously, optimizing device designs for modularity and manufacturability can reduce vulnerability to tariff and supply-chain disruptions while retaining clinical functionality.

On the commercial front, firms should expand flexible procurement options, such as leasing, consumable-based pricing, and bundled service agreements, to alleviate buyer sensitivity to capital constraints and to highlight total cost advantages. Strengthening clinical training programs and remote support capabilities will accelerate clinician proficiency and enhance patient outcomes, thereby reducing churn and elevating word-of-mouth endorsement. Moreover, deepening digital capabilities for patient engagement and post-treatment monitoring can improve adherence to multi-session regimens and demonstrate real-world effectiveness.

Strategic partnerships with regional distributors, academic centers, and accredited training providers will be essential to scale adoption across heterogeneous geographies. Finally, scenario planning for trade and regulatory changes, including proactive supplier diversification and inventory strategies, will reduce operational risk and preserve market responsiveness under shifting policy conditions.

A transparent, practitioner-informed research methodology combining primary clinician interviews and rigorous secondary evidence synthesis to ensure actionable conclusions

The research underpinning this analysis synthesizes primary qualitative insights with secondary evidence to deliver a rigorous perspective on clinical adoption, technology performance, and commercial dynamics. Primary inputs were derived from structured interviews with clinicians, device engineers, distributor executives, and clinical educators, providing front-line perspectives on treatment workflows, device preferences, and purchasing considerations. These practitioner voices were triangulated with technical literature, regulatory filings, and company disclosures to validate claims regarding device capabilities and safety profiles.

Secondary analysis incorporated peer-reviewed clinical studies, conference proceedings, and publicly available regulatory guidance to inform understanding of efficacy, safety considerations, and clinical best practices. Where possible, longitudinal data from clinical registries and real-world evidence sources were examined to assess durability of outcomes and practitioner satisfaction. The synthesis emphasized methodological transparency, documenting data sources, interview protocols, and analytical assumptions to support reproducibility and critical review.

Throughout, attention was given to minimizing bias by sampling diverse geographies, practice settings, and technology types. Limitations related to proprietary clinical data and rapidly evolving device iterations were explicitly noted, and recommendations were calibrated to account for these constraints. This methodological approach yields pragmatic insights suitable for commercial decision-making and clinical planning.

A concise conclusion emphasizing the nexus of clinical validation, resilient commercialization, and adaptive product strategy as the keys to future success

In summary, non-surgical skin tightening is undergoing a period of purposeful maturation as device innovation, clinical evidence, and consumer preferences coalesce to reshape care pathways. Energy modalities are diversifying in technological design and clinical application, necessitating nuanced positioning that aligns device capability with anatomical and procedural demands. Adoption patterns are influenced by regional regulatory frameworks, shifting trade policies, and evolving distribution channels, which together create a dynamic operating environment for manufacturers, clinicians, and distributors.

To succeed, stakeholders must integrate clinical validation, flexible commercial offers, and resilient supply-chain strategies. Emphasizing training, post-sale service, and outcome measurement will accelerate practitioner confidence and patient satisfaction. Meanwhile, responsive product design and modular manufacturing can mitigate tariff exposure and support scalable regional launches. Ultimately, organizations that combine clinical rigor with strategic commercial execution will be best positioned to capture the opportunity presented by rising demand for effective, low-downtime skin tightening solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-surgical Skin Tightening Market, by Technology

  • 8.1. Infrared
    • 8.1.1. Far Infrared
    • 8.1.2. Near Infrared
  • 8.2. Laser
    • 8.2.1. Diode
    • 8.2.2. Erbium
    • 8.2.3. Nd:YAG
  • 8.3. Radio Frequency
    • 8.3.1. Bipolar
    • 8.3.2. Monopolar
    • 8.3.3. Tripolar
  • 8.4. Ultrasound
    • 8.4.1. High Intensity Focused Ultrasound
    • 8.4.2. Microfocused Ultrasound

9. Non-surgical Skin Tightening Market, by Application

  • 9.1. Body
    • 9.1.1. Abdomen
    • 9.1.2. Arms
    • 9.1.3. Buttocks
    • 9.1.4. Thighs
  • 9.2. Face
    • 9.2.1. Cheeks
    • 9.2.2. Chin
    • 9.2.3. Forehead
    • 9.2.4. Neck

10. Non-surgical Skin Tightening Market, by End User

  • 10.1. Aesthetic Centers
  • 10.2. Dermatology Clinics
  • 10.3. Home Use
  • 10.4. Hospitals
  • 10.5. Medical Spas

11. Non-surgical Skin Tightening Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Non-surgical Skin Tightening Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-surgical Skin Tightening Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-surgical Skin Tightening Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Non-surgical Skin Tightening Market

16. China Non-surgical Skin Tightening Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BTL Industries, Inc.
  • 17.6. Candela Corporation
  • 17.7. Cutera, Inc.
  • 17.8. Cynosure, LLC
  • 17.9. El.En. S.p.A.
  • 17.10. InMode Ltd.
  • 17.11. Lumenis Ltd.
  • 17.12. Lutronic Corporation
  • 17.13. Merz Pharma GmbH & Co. KGaA
  • 17.14. Sisram Medical Ltd.
  • 17.15. Venus Concept Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FAR INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FAR INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FAR INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NEAR INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NEAR INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NEAR INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DIODE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DIODE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DIODE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ERBIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ERBIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ERBIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ND:YAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ND:YAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ND:YAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BIPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MONOPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TRIPOLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TRIPOLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TRIPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HIGH INTENSITY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MICROFOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MICROFOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MICROFOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ABDOMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ABDOMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ABDOMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BUTTOCKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BUTTOCKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BUTTOCKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY THIGHS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY THIGHS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY THIGHS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHEEKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHEEKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHEEKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY CHIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FOREHEAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FOREHEAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FOREHEAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NECK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NECK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY NECK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY AESTHETIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY AESTHETIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY AESTHETIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MEDICAL SPAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY MEDICAL SPAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 209. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 210. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 212. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 242. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 243. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 245. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 247. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 248. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 253. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 254. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 256. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 259. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. NATO NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY INFRARED, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY LASER, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY RADIO FREQUENCY, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY ULTRASOUND, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY BODY, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY FACE, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA NON-SURGICAL SKIN TIGHTENING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)